Advisory Services Network’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Advisory Services Network’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-890	Closed	-$789	–	4189
2022 Q4	$789	Buy	+890	New	+$1.18K	﹤0.01%	3639
2022 Q2	–	Sell	-24,810	Closed	-$58K	–	1534
2022 Q1	$58K	Buy	+24,810	New	+$77.4K	﹤0.01%	1417
2021 Q1	–	Sell	-1,138	Closed	-$8K	–	3176
2020 Q4	$8K	Buy	1,138 +714	+168%	+$5.74K	﹤0.01%	2568
2020 Q3	$5K	Buy	+424	New	+$3.88K	﹤0.01%	2807
2020 Q1	–	Sell	-10,000	Closed	-$34K	–	3365
2019 Q4	$34K	Buy	+10,000	New	+$23.8K	﹤0.01%	1720

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Advisory Services Network's SRNE Position: Q1 2023 in Review

Advisory Services Network sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 890 shares — an estimated $789 sold.

Advisory Services Network first reported a position in SRNE in Q4 2019 and held it in 5 quarters. The position peaked at $58K in Q1 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Advisory Services Network reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Advisory Services Network sold 890 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $789.
Advisory Services Network first reported a position in Sorrento Therapeutics, Inc. in Q4 2019 and held it in 5 quarters.
Advisory Services Network's Sorrento Therapeutics, Inc. position peaked at $58K in Q1 2022.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Advisory Services Network's 13F filing for Q1 2023, filed 17 May 2023.